Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry H Gurwitz

Showing results (1-10 of 307) with videos related to

Pageof 31
Sort By:
Journal of the American Geriatrics Society|March 13, 2025
Pulling Back the Curtain on Deprescribing InterventionsJerry H Gurwitz
The New England Journal of Medicine|March 3, 2006
Serious adverse drug effects--seeing the trees through the forestJerry H Gurwitz
Journal of the American Geriatrics Society|June 6, 2025
Does Documenting a Dementia Diagnosis Improve Outcomes?Jerry H Gurwitz
The American Journal of Medicine|April 20, 2012
The physics of geriatric pharmacotherapy: overcoming therapeutic inertia and momentumJerry H Gurwitz
The New England Journal of Medicine|February 25, 2003
Testing medications in childrenJerry H Gurwitz
BMJ (Clinical Research Ed.)|July 6, 2011
NSAIDs and atrial fibrillationJerry H Gurwitz
Journal of the American Geriatrics Society|October 6, 2018
Pharmaceutical Marketing at the 2018 American Geriatrics Society Annual Scientific Meeting: The Case of Noctiva and the Need for Increased VigilanceJerry H Gurwitz
The Virtual Mentor : VM|May 23, 2014
The exclusion of older people from participation in cardiovascular trialsJerry H Gurwitz
Journal of Women'S Health (2002)|February 5, 2005
The age/gender interface in geriatric pharmacotherapyJerry H Gurwitz
Journal of the American Geriatrics Society|April 22, 2020
COVID-19, Post-acute Care Preparedness and Nursing Homes: Flawed Policy in the Fog of WarJerry H Gurwitz
Pageof 31

Showing results (1-10 of 307) with videos related to

Sort By:
Pageof 31
Journal of the American Geriatrics Society|March 13, 2025
Pulling Back the Curtain on Deprescribing InterventionsJerry H Gurwitz
The New England Journal of Medicine|March 3, 2006
Serious adverse drug effects--seeing the trees through the forestJerry H Gurwitz
Journal of the American Geriatrics Society|June 6, 2025
Does Documenting a Dementia Diagnosis Improve Outcomes?Jerry H Gurwitz
The American Journal of Medicine|April 20, 2012
The physics of geriatric pharmacotherapy: overcoming therapeutic inertia and momentumJerry H Gurwitz
The New England Journal of Medicine|February 25, 2003
Testing medications in childrenJerry H Gurwitz
BMJ (Clinical Research Ed.)|July 6, 2011
NSAIDs and atrial fibrillationJerry H Gurwitz
Journal of the American Geriatrics Society|October 6, 2018
Pharmaceutical Marketing at the 2018 American Geriatrics Society Annual Scientific Meeting: The Case of Noctiva and the Need for Increased VigilanceJerry H Gurwitz
The Virtual Mentor : VM|May 23, 2014
The exclusion of older people from participation in cardiovascular trialsJerry H Gurwitz
Journal of Women'S Health (2002)|February 5, 2005
The age/gender interface in geriatric pharmacotherapyJerry H Gurwitz
Journal of the American Geriatrics Society|April 22, 2020
COVID-19, Post-acute Care Preparedness and Nursing Homes: Flawed Policy in the Fog of WarJerry H Gurwitz
Pageof 31